Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Creative Bioarray

Located at Long Island, New York, Creative Bioarray was founded as biomedical company focused on providing comprehensive biotechnology and pharmaceutical array services and products for high-throughput analysis. Creative Bioarray uniquely pioneers the development of high quality tissue, antibody, protein and cell array technology to efficiently analyze the concurrent expression and function of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

Creative Bioarray
45-16 Ramsey Road Shirley, New York, NY 11967, United States
+1 631 624 4882
Contact Creative Bioarray
Website

 Latest Content from PMHub 

Events:

White Papers and Resources | September 1, 2021 | Inizio

Patient Centricity and Engagement Conference 2021

Parallel HCP-Patient Advisory Boards: A Customer Story

White Papers and Resources | August 31, 2021 | Impetus Digital

Learn how a Pharma team engaged both dermatologists and patients with psoriasis in two parallel virtual advisory boards.

Hepatitis (C)an’t wait: taking a de-centralized approach to cure the epidemic

White Papers and Resources | August 31, 2021 | Avalere Health

Hepatitis C is a curable disease, so why are so many countries off track to achieve the World Health Organization elimination target? This World Hepatitis Day, we compare several countries’...

Courageous Conversation ep.10: Facial Recognition Software in Healthcare

Videos and Podcasts | August 27, 2021 | Impetus Digital

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on Facial Recognition Software in Healthcare.

Transforming the Future of Health & Aging from a Global Health & Social Impact Approach

Videos and Podcasts | August 27, 2021 | Impetus Digital

Dr. Zayna Khayat, Future Strategist at SE Health, dives into the future of aging and healthcare in Canada, including the roles of emerging technologies, the shift to people-powered healthcare, and...

Webcast:

White Papers and Resources | August 26, 2021 | Inizio

UX beyond the website: Insights for the age of omnichannel

A holistic approach to managing pressure in MedComms

Videos and Podcasts | August 24, 2021 | Fox&Cat

Who cares… about great healthcare creative?

Press Releases | August 20, 2021 | 11 London

Prestigious awards for healthcare communications tend to be dominated by the big network agencies and their offshoots. And the work deserves the wins. Imaginative, innovative, powerful, arresting – it’s all...

Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery

Videos and Podcasts | August 19, 2021 | Impetus Digital

Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve...

Top-10 ways that Pharma teams can fight the climate crisis

White Papers and Resources | August 17, 2021 | Impetus Digital

Ten easy steps that individual medical, marketing, clinical, regulatory, and market access teams can take to reduce their own footprints.